Confirmation that humans are exposed to chemicals that interfere with the hormonal system (endocrine disrupters) has prompted many epidemiological studies but an association between chemical residues and disease remains elusive. Exposure to these chemicals occurs mainly through diet, water, environment, indoor air, dust, soil, and also in an occupational setting. For example, organochlorine pesticides and polychlorinated biphenyls (PCB) enter the human organism via food and water but they also may reach humans by inhalation and contact, especially among those professionally exposed in industrial and agricultural settings. Many of these organochlorine derivatives accumulate in adipose tissues because of their solubility in lipids and their inefficient metabolism.
Since 1970, the use of some organochlorines has been banned, leading to a reduction in their accumulation in the environment and a decrease, albeit slower, in the human body burden (1) . Other organochlorine pesticide, including endosulfan, are still used and frequently found in the environment (2) and in human tissues and fluids (3) . Historic exposure to bioaccumulative xenoestrogens is reconstructed through study of the body burden, mostly blood and adipose tissue content (4) and of medical records and with the use of questionnaires. These methods permit investigation of the association between exposure to persistent organochlorines and long latency diseases such as breast cancer. Over the past 16 years, many studies have reported a wide range of pesticide content in the adipose tissue of breast cancer patients, not only dichlorodiphenyltrichloroethane (DDT) and its metabolites (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) , but also hexachlorobenzene (7-8, 10, 13-14) mirex, chlordane, and b-hexachlorocyclohexane (14) . Experimental data confirmed the estrogenicity of many of these fatsoluble chemicals, which are now classified as xenoestrogens (14) . However, there has been no demonstration to date of a clear connection between exposure to these chemicals and hormone-dependent diseases, or of the role of these xenobiotics in the modulation of cancer growth (15-16).
It was stated (17) that the design of retrospective breast cancer studies based on the analysis of human samples should consider the hypothesis to be tested, the chemicals to be measured, and the biological activity to be analysed. However, these considerations are frequently disregarded. For example: i) many studies have included chemicals that are not hormonally active, taking no account of the role of estrogens in the pathogenesis of the disease, ii) other studies have only measured a single residue because of the time, resources and the large sample sizes required to determine more chemicals, and iii) most of the studies have disregarded cumulative effects and interactions between chemicals. There is a need to develop markers of estrogenic exposure that go further than the quantification of isolated xenoestrogens. It has been proposed (18) that rather than measuring the levels of identified xenoestrogens, it might be more meaningful to assess the risk of endocrine disruption by measuring the biological activity resulting from the xenobiotics.
We adopted this approach and developed a system to estimate the total estrogenic xenobiotic burden in serum samples (19) using the EScreen, an in vitro bioassay of proven utility for the identification of xenoestrogens (20) . This bioassay compares the cell yield between cultures of human breast cancer MCF-7 cells treated with estradiol and those treated with different concentrations of xenobiotics suspected of being estrogenic (18, (21) (22) . We then developed a methodology to extract xenoestrogens from human fat samples, separating sex steroids from bioaccumulated xenoestrogens and testing them in the E-Screen bioassay (23) (24) .
The purpose of the present study was to standardise and apply a method to extract xenoestrogens from the adipose tissue of 400 patients and test them for estrogenicity using the EScreen bioassay. In addition, residues of sixteen organochlorine pesticides and their metabolites were quantified in the fat of the same patients. Some of the chemicals tested are already identified as estrogenic mimics but others are defined here as estrogenic agonist for the first time.
MATERIAL AND METHODS

Patients
Four hundred women with different diseases who were undergoing surgical treatments were included in the study; the mean age was 53 years. Fat samples were taken from mammary or abdominal fatty tissue. Adipose tissue collected during surgical treatment at Granada University Hospitals and Almeria Hospital was placed into a glass vial on ice, coded, and frozen to ª70ae C, always within 30 min of being excised, and stored at the same temperature at the Laboratory of Medical Investigations until they were processed.
Reagents
All solvents used were of high purity grade for HPLC: Methanol, 2-isopropanol, hexane, ethanol, chloroform, hydrochloric acid (Panreac, Barcelona, Spain). Patterns: Aldrin, dieldrin, endrin, lindane, methoxychlor, endosulfan I and II, mirex, p-p'-DDT and o-p'-DDT (Supelco, Bellefonte, PA); o,p'-DDD, PCB 77, 126 and 169 and p-p'dichlorobenzophenone (Dr Ehrenstorfer Lab., Ausburg, Germany); p,p'-DDE (Chem Service, West Chester, PA); endosulfan metabolites, endosulfan diol, sulfate, lactone and ether (Hoechst Schering AgrEvo, Frankfurt, Germany); biochanin A, a-zearalenol, b-zearalenol, diethylestilbestrol, 17b-estradiol, 17a-estradiol, estrone, 17a-ethynylestradiol, progesterone and testosterone (Sigma, St. Louis, MI); bisphenol-A (Aldrich Chemical Company, Milwaukee, WI).
Bisphenol derivatives with substituents at the central carbon and phenol ring, 1,1 bis (4-hydroxyphenyl) ethane (MM1), 1,1 bis (4-hydroxyphenyl) propane (MM2), 2,2 bis (4-hydroxyphenyl) butane (MM3), 3,3 bis (4-hydroxyphenyl) pentane (MM4), 4,4 bis (4-hydroxyphenyl) heptane (MM5), 2,2 bis (4-hydroxy-3-methylphenyl) propane (MM6), 2,2 bis (4-hydroxyphenyl) perfluoropropane (MM7), bis (4-hydroxyphenyl) ketone (MM8) and 2,2-bis(4-hydroxyphenyl) propanol (MM9) were synthesized by Dr. M. Metzler of Karlsruhe University (Karlsruhe, Germany). Chlorinated bisphenols, mono-, di-, tri and tetrachloro-bisphenol-A were a gift from Dr. J.L. Vilchez (Analytical Chemistry Dpt. University of Granada, Spain). p-Nonylphenol was purchased from Fluka Chemika (Buchs, Switzerland), bromine-p-nonylphenol acetate (BrNPAc), bromine-p-nonylphenol monoethoxylated acetate (BrNP1EOAc) and bromine-p-nonylphenol diethoxylated acetate (BrNP2EOAc) were a gift from Dr. F. Ventura (Agbar, Barcelona, Spain). The purity of all of these chemicals was at least 97%. The chemicals were dissolved in ethanol to a final concentration of 1 mM and stored at ª20 aeC.
Apparatus
The HPLC procedure was done with a Waters Model 501 Millipore apparatus (Marlborough, MA) equipped with two pumps and a U6K injector of 500 mL load capacity. Ultraviolet/visible detector was a Waters Model 490 Millipore set at 280 nm and Millennium Chromatography Manager software was used. A Lichrocart column (25 cm¿4.6 mm) was used (Merck, Darmstadt, Germany) packed with Lichrospher Si-60, of 5 mm particle size. Gas chromatography was done with a Varian-3350 machine (Walnut Creek, CA) with electron capture detector ( 63 Ni) and using Millennium Chromatography Manager software. A methyl silicone column (30 m¿0.25 mm) was used. Gas chromatography-Mass spectrometry was done with a Saturn 2000 Varian Instrument (Walnut Creek, CA) with automatic injector 8200, SPI/1078; a DB5-MS capillary column (30 m¿0.25 mm) was used.
Extraction of xenoestrogens from adipose tissue and separation of sex steroids
Sample extraction. Samples were processed in batches of six. Two quality control samples were run every two batches. Bioaccumulative compounds were extracted from adipose tissue by a previously described method (25) , with slight modifications. An aliquot of 200 mg adipose tissue was dissolved in hexane and eluted in a glass column filled with Alumine Merck 90 (70-230 mesh) no. 1097 that had been dried at 600 aeC for 4 h and rehydrated with the addition of 5% water. The eluate obtained was concentrated at reduced pressure and then under a stream of nitrogen to a volume of 1 mL and then injected twice (500 mL) into the preparative HPLC. Spiked fat samples were run in parallel in order to assess the recovery of pesticides from adipose tissue. Aliquots were spiked with a known amount of standard solutions of pesticides, homogenised and allowed to equilibrate for 2 hours at room temperature. The recovery and reproducibility of the process was established by running ten fat samples.
High performance liquid chromatography (HPLC).
A preparative liquid chromatography method was developed to allow the separation of the more lipophilic xenoestrogens from natural estrogens without destroying them. Extracts were eluted by a gradient with two mobile phases: n-hexane (phase A) and nhexane: methanol: 2-isopropanol (40:45:15)(v/v) (phase B) at a flow rate of 1.0 mL/min. The gradient programme was based on a previously described method (26) with modifications. Working conditions were: gradient tΩ0 min, 100% phase A; tΩ17 min, 60% phase A; tΩ25 min, 100% phase B; tΩ32 min, 100% phase A. Three pooled fractions, named a, x and b, were separated by HPLC. The a fraction is collected in the first 11 minutes, the x fraction is collected between minutes 11 and 12, and the ß fraction is collected between minutes 12 and 25. The method was employed under similar working conditions except for an injection volume of 20 mL of standard solutions, in order to establish the retention times of the chemicals eluted in the a, x and ß fractions.
Gas chromatography (GC). a-fractions of HPLC chromatography were dried, dissolved in n-hexane, spiked with an internal standard (p,p'-dichlorobenzofenone) and then injected into a gas chromatograph with an electron capture detector (ECD). In the gas chromatography, no organochlorine chemicals were detected in the x and ß fractions. Standard solutions of organochlorine pesticides were previously analysed by gas chromatography in order to determine the retention times and calibration curves of these chemicals. The working conditions were: ECD at 300 aeC; injector at 250 aeC; Program: Initial T 130 aeC (1 min); 20 aeC/min to 150 aeC; 10ae C/min to 200 aeC; 20 aeC/min to 260 aeC (20 min). The carrier gas was Nitrogen at a flow of 30 mL/min and the auxiliary gas Nitrogen at a flow of 40 mL/min. The injection volume was 1 mL. The reproducibility of the process was established by running ten fat samples 10 times. The presence of organochlorine in fraction a was confirmed by gas chromatography and mass spectrometry (GC/MS), following the working conditions previously described (27) (28) . The working conditions were: Oven T: 80 aeC (2.5min), 50 aeC/min until 140 aeC, 5 aeC/min to 260 aeC during 3 min; Injector T: initial temperature 90 aeC (0.1 min), 200 aeC/min to 280 aeC; gas He; injector flow: 1mL/sec. Injection volume 1 mL.
Lipid determination. Total lipid content was quantified gravimetrically: 100 mg of adipose tissue were homogenised in 2.5 mL of chloroform:methanol:hydrochloric acid (20:10:0.1). After repeating the process, 5 mL of HCl 0.1N were added and centrifuged at 3000 rpm for 10 min. The organic phase was collected; the non-organic phase was extracted again and added to the first extraction product. After drying under a nitrogen stream, the tubes were weighed and the total lipid expressed in g of lipid per g of adipose tissue.
Bioassay for measuring estrogenicity
MCF-7 cell line. Cloned MCF-7 cancer cells were grown for routine maintenance in Dulbecco's modification of Eagle's medium supplemented with 5% fetal bovine serum (BioWittaker, Walkersville, MD) in an atmosphere of 5% C0 2 /95% air under saturating humidity at 37 aeC. The cells were subcultivated at weekly intervals using a mixture of 0.05% trypsin and 0.01% EDTA.
Charcoal-dextran treatment of serum. Plasma-derived human serum was prepared from outdated plasma by adding calcium chloride to a final concentration of 30 mM to facilitate clot formation. Sex steroids were removed from serum by charcoal-dextran stripping. Briefly, a suspension of 5% charcoal (Norit A, Sigma Chemical Co, St. Louis, MO) with 0.5% dextran T-70 (Pharmacia-LKB, Uppsala, Sweden) was prepared. Aliquots of the charcoal-dextran suspension of a volume similar to the serum aliquot to be processed were centrifuged at 1000 g for 10 min. Supernatants were aspirated and serum aliquots were mixed with the charcoal pellets. This charcoal-serum mixture was maintained in suspension by rolling at 6 cycles/min at 37 aeC for 1 h. The suspension was centrifuged at 1000 g for 20 min, and the supernatant was then filtered through a 0.22 mm filter (Millipore). Charcoal dextran-treated human serum (CDHuS) was stored at ª20 aeC until needed. In addition manufactured CDHuS from Irvine Scientific (Santa Ana, CA) was also employed.
Cell proliferation experiments. MCF-7 cells were used in the test of estrogenicity according to a technique slightly modified (22) from that originally described (20) . Briefly, cells were trypsinized and plated in 24-well plates (Limbro, McLean, VA) at initial concentrations of 20.000 cells per well in 5% FBS in DME. Cells were allowed to attach for 24 h; then the seeding medium was replaced with 10% CDHuSsupplemented phenol red-free DME. Different concentrations of the test compound were added, and the assay was stopped after 144 h by removing medium from wells, fixing the cells and staining them with sulforhodamine-B (SRB). The cells were treated with cold 10% trichloroacetic acid and incubated at 4 aeC for 30 min, washed five times with tap water and left to dry. Trichloroacetic-fixed cells were stained for 10 min with 0.4% (wt/vol) SRB dissolved in 1% acetic acid. Wells were rinsed with 1% acetic acid and air dried. Bound dye was dissolved with 10 mM Tris base (pH 10.7) in a shaker for 20 min. Finally, aliquots were transferred to a 96-well plate and read in a Titertek Multiscan apparatus (Flow, Irvine, CA) at 492 nm. The linearity of the SRB assay with cell number was verified prior to the cell growth experiments. The 100% proliferative effect (PE) was calculated as the 188 ratio between the highest cell yield obtained with 50 pM of estradiol and the proliferation of hormonefree control cells.
Quantitative evaluation of estrogenicity of chemicals. Ethanol solutions of pure chemicals were prepared at 1 mM and tested in quadruplicate in three different assays in a range of 0.1 mM to 1 pM. The proliferative effect (PE) of any chemical indicates the lowest concentration needed for maximal cell yield. The relative proliferative effect (RPE) is calculated as 100 ¿ (PE-1) of the test compound/(PE-1) of estradiol. A value quantitatively similar to estradiol (RPEΩ 100) indicates that the compound tested is a full agonist, a value of 0 indicates that the compound lacks estrogenicity at the doses tested, and a value of significantly lower than estradiol suggest that the xenobiotic is a partial agonist. Relative proliferative potency (RPP) is the ratio between the estradiol and xenobiotic doses needed to produce maximal yield ¿ 100. All the compounds designated as full or partial agonists (RPEϾ15) significantly increased cell yields compared to the controls without hormones (pϽ0.05).
Quantitative evaluation of estrogenicity of fat extracts: Duplicated dry pooled a and ß fractions obtained by preparative HPLC chromatography were resuspended in 5 mL of CDHuS supplemented phenol red-free medium, vigorously shaken and left at rest for 30 min, then filtered throughout a 0.22 mm filter and tested in the assay for estrogenicity at dilutions from 1:1 to 1:10. Each sample was analysed in triplicate with a negative (vehicle) and a positive (estradiol 10 pM) control in each plate. The PE of a and ß fractions was referred to the maximal proliferative effect obtained with estradiol and transformed into estradiol equivalent units (Eeq) by reading from a dose-response curve prepared using estradiol (Concentration range 0.1 pM to 10 nM).
Statistical analysis
Results from cell proliferation experiments were expressed as means∫SD. Proliferation yield experi- 
RESULTS
Extraction and separation of non-polar xenoestrogens from sex-steroids by HPLC
The methodology developed allowed the quantitative extraction of xenoestrogens from human adipose tissues. The recovery percentages of samples spiked with a mixture of organochlorines were always higher than 83% (Table  1) . Extracted xenoestrogens and natural sexsteroids were separated by HPLC into three different fractions: the first 11 mL (0-11 min) of elution corresponded to the a fraction, the next 2 mL (11-12 min) to the x fraction and the last 13 mL (12-25 min) collected to the ß fraction. This normal-phase column separated xenoestrogens according to their polarity; with the most lipophilic compounds retained for the shortest time. Organochlorine pesticides, chlorinated bisphenols and brominated p-nonylphenol eluted notably earlier than the steroidal estrogens ( Table 2 ). These data indicate that the non-polar xenoestrogens can be successfully separated from sex steroids, phytoestrogens, mycoestrogens and bisphenols. The a, x and b fractions were analysed by GC/ECD and also tested in the bioassay for estrogenicity. The x fraction is a consequence of the gradient used in the elution process; it has the meaning of a safety fraction with no chemicals recorded in UV or GC-ECD, which separates the a fraction containing the more lipophilic substances from the b fraction where natural estrogens and more polar xenoestrogens eluted. The mean percentage of lipid content in the fat samples gathered in the present study was higher than 80%.
Identification and quantification of organochlorine pesticides
The GC demonstrated that organochlorine pesticides were eluted in the a fraction. The retention times of these chemicals are shown in Table 3 , together with the detection (LOD) and quantification limits (QL). The calibration linearity of the 16 pesticides in pure and processed standards was greater than 0.98. The reproducibility for the GC/ECD results in an adipose tissue sample tested 10 times is shown in Table  4 . The mean values of the organochlorine pesticides measured in the extracted adipose tissue Table 5 . p,p'-DDE was the commonest residue found in our series of patients and 98% of the assayed samples showed measurable amounts of this pesticide. It was followed in frequency by endosulfans and some of their metabolites (Range 52-11%) and by hexachlorocyclohexane lindane (42%). The order of organochlorine pesticides by concentration level was: p,p'-DDE Ͼo,p'-DDD Ͼ endosulfan-sulfate Ͼ mirex Ͼ endrin Ͼ lindane Ͼ among the pesticides that showed levels of Ͼ40 ng/g of lipid concentration. The p,p'-DDT and some of the cyclodiene derivatives occupied the next highest positions, whereas endosulfans and their metabolites and dieldrin were found at lower concentrations. GC/MS always confirmed the presence of the organochlorine pesticides in the a-fraction (data not shown). No organochlorine pesticides were found in the x or ß fractions.
Estrogenic effect of chemicals
Culture bioassays for estrogenicity commonly use MCF-7 breast cancer cells, an estrogen-sensitive and -dependent cell line. We used an EScreen MCF-7 based bioassay to test the chemicals suspected of being hormone-mimics. The addition of estradiol to CDHuS-supplemented medium increased the number of MCF-7 cells in the culture. The maximum PE was obtained at concentrations of 50 pM estradiol and higher ( Figure 1 ). The cell yields were 6-fold greater (PE-1) of the test compound/(PE-1) of estradiol, where PE is the lowest concentration needed for maximal cell yield (PE); RPP is the ratio between estradiol and xenobiotic doses needed to produce maximal yield ¿ 100. All of the compounds that were designated as full or partial agonists (RPEϾ15) significantly increased cell yields compared with the controls without hormones (pϽ0.05). -no effect observed. (Figure 3) . The means and medians are expressed as the estradiol equivalent (Eeq) estimated for 1 mL of culture medium in the E-Screen assay and are expressed in Eeq/g of lipids after adjustment for the sample weight, lipid content and dilution factor of the dried extracts. M, mean; SD, standard deviation. than in control cultures after 6 days (mean∫SD, 6.01∫1.03 in 10 experiments). In the absence of estradiol (controls), the cells proliferated minimally. The PEs of endosulfans, brominated alkylphenols and chlorinated bisphenols are shown in Figure 1 and Table 6 . PE was significantly greater than 1 for all the compounds tested except for endosulfan lactone and sulfate, which were negative in the bioassay. In comparison with the RPE of estradiol, all the positive compounds showed a full to partial agonistic response that produced cell yields ranging from 85% of estradiol-induced yield for bisphenol-A to 30% for tetrachlorine bisphenol-A derivative.
Testing the estrogenic activity of the adipose tissue extract
Fractions a, x and ß were tested in the EScreen bioassay in order to determine the total estrogenic xenobiotic burden corresponding to each sample. The first step towards this end was to define the dose-proliferative response curve for estradiol and MCF-7 cells, as a standard (Figure 2 ). At concentrations below 1 pM estradiol, equivalent to 1 fmol in 1 ml of culture medium, the mean of cell numbers did not differ significantly from that of the steroid-free control. Thus, 1 fmol estradiol/well was determined as the lowest detectable estrogen amount in this assay. The proliferative effects obtained with 1:1 to 1:10 dilutions of a, x and ß fractions were converted to estradiol equivalents (Eeq) by interpolation on the estradiol dose-response curve. No activity was found when testing the x fraction, therefore no data are presented. Figure  3 shows the proliferative effect corresponding to the dilutions of a and ß fractions of a fat sample chosen from among those giving a positive re-192 sponse. Table 7 lists the mean Eeq/g lipid values for a and ß-fractions in all the 400 samples studied; 78% of samples showed measurable estrogenic activity in the a-fraction, with a mean value of 750 pM (range, 2.7 pM to 1.8 nM). In addition, 83 % of ß-fractions were positive in Fig. 2 . Dose-response curve of estradiol on MCF-7 cells in culture. Cells were harvested after 6 days of exposure to variable amounts of estradiol. Ordinate: RPE calculated as 100 ¿ (Proliferative effect -1) of each estradiol concentration/(Proliferative effect -1) of plateau estradiol concentrations (0.1 nM estradiol and higher). Data points represent the mean of sets of four experiments repeated every twenty tests; the error bars represent the SD. Logit transformation of data fit a straight line, with a correlation coefficient rΩ0.956. Fig. 3 . Bioactivity of an adipose tissue extract on MCF-7 cells in culture. Data points represent the mean of proliferation treated/control ratio of serial dilutions of a (unfilled circle) and ß (filled circle) fractions. Dotted line: negative control, cell yield in the absence of chemicals. The proliferative effect of a and ß fractions was referred to the proliferative effect of estradiol (Dose response curve of estradiol) and transformed into Eeq units; the results were 124 pM/ mL and 20 pM/mL, respectively. the E-Screen assay, with a mean value of 903 pM (range, 3.4 pM to 5.6 nM). Absence of toxic activity in the extracts was demonstrated when partial agonist effect was shown in the presence of 100 pM of estradiol at maximal dilution of the extracts (data not shown).
Quality control of the method
To study the precision of the procedure, 24 aliquots of 200 mg were extracted from two fat samples previously assigned as having a low (8 pM/mL) and high (120 pM/mL) level of estrogenicity, respectively. The aliquots underwent preparative HPLC and were assayed in the EScreen. The calculation of Eeq/mL was made independently for each sample. At each step throughout the process four samples were pooled out (Pool), eluted, and re-included in the process. A good reproducibility (mean∫SD, 120.0∫38. 
DISCUSSION
Humans are exposed to endocrine disrupters of very varied origin through diet and in other ways, especially through different types of exposure at the workplace. For example, individuals employed in intensive greenhouse agriculture in Southern Europe have been shown to be subject to high exposure levels (3, 29) . Once inside the body, endocrine disrupters can act cumulatively or in combination with endogenous hormones. Some of these chemicals, such as organochlorine chemicals, accumulate and persist in adipose tissue due to their lipid solubility and resistance to metabolisation, reaching levels 200-1000-fold those found in serum (14) . Therefore, fat deposits can maintain elevated levels of organochlorine and PCBs in the circulation for years, (4) even when there has been no exposure during this period. Serum levels of organochlorines are frequently used as biomarkers of exposure, on the assumption that they represent fat reservoir content and are reliable indicators of total body burden (30) . However, a perfect relationship between serum levels and adipose tissue content is not always evident. Several authors have recommended the direct measurement of adipose tissue content (4, 17, 14) . The procedures described in the present paper constitute the standardisation of a marker of human exposure to biocumulative xenoestrogens that permits the quantitation of estrogenicity. We measured the combined estrogenic effect of chemicals extracted from adipose tissue by determining the cumulative effect of the xenoestrogens with the E-screen bioassay for estrogenicity. The process ended with assessment of the proliferative effect, expressed in estradiol equivalents per gram of lipid content (Eeq/g), and assignation of the total estrogenic burden to each patient. We demonstrated a high pro-portion of individuals with estrogenic activity attributable to estrogens accumulated in adipose tissue. The mean value of Eeq/g of lipid for the a-fraction was established at 750 pM/g for 304 samples (76% of the series), equivalent to 24 fmol/mL of estradiol in the culture medium, corresponding to a segment of the standard curve that provides more precise discrimination. After taking into account the sensitivity of the method (1 fmol/mL) and the dilution factor, the percentage of samples considered positive was adjusted to 65%.
We do not know which chemicals are responsible for estrogenicity of the samples, but organochlorine pesticides, PCBs and halogenated bisphenols and alkylphenols emerged as candidates because they were collected in the most lipophilic, non-polar a-fraction of the preparative HPLC. The organochlorine concentrations measured in the a-fraction are comparable to those previously reported in adipose tissue from different sites. For example, The mean value of 505 ng of p,p'-DDE /g of lipid that we found is similar to a recently reported finding of 596-693 mg/Kg for breast adipose tissue (14) but much lower than values reported in the USA in 1987 (8) . Results for residues of the parent compound of p,p'-DDE show some discrepancies. The p,p'-DDT value in our series was two-fold that reported in other series (14) . These differences were even more marked for residues of other organochlorines such as mirex, which we found at five times the concentrations described by other authors (14) , although only in 7% of our series. We included DDT isomers and metabolites, cyclodiene derivatives and hexachlorocyclohexane pesticides in the present study because of the interest in running epidemiological studies on these chemicals. For example, these organochlorines have been studied in relation to breast cancer, either because they fit the xenoestrogen hypothesis that links hormonally active chemicals to the risk of hormonal disease (31), or because they may act as direct carcinogens. We also included in the study a group of endosulfans, isomers and metabolites, because some of them are weak estrogens and may therefore be related to hormonal imbalance, although our findings cannot be compared because of the absence of published data on endosulfans.
The results for DDT isomers and those for their metabolites correlated with each other. We 194 found a significant correlation between o,p'-DDT and p,p'-DDT (|Ω0.116; pϽ0.016), perhaps because commercial grade DDT, mainly the p,p'-isomer, typically has 15% of the o,p'-isomer. The concentrations of o,p'-isomers in humans are frequently low and may be undetectable in specimens of the size normally collected (17) . However, these good correlations have led to proposals for the p,p'-measurement to be used as a surrogate biomarker suitable for epidemiological purposes. p,p'-DDE was also significantly correlated with p,p'-DDT (|Ω0.190; pϽ0.0001) but not with p,p'-DDT or DDD. p,p'-DDE is the most prominent environmental residue of DDT, a metabolite that constitutes approximately 90% of the total residues in humans.
Endosulfans I and II and their metabolites were also related to each other. We found a significant correlation between endosulfan I and II (|Ω0.114, pϽ0.018) and both of them correlated with endosulfan ether, lactone, and diol but not with endosulfan sulfate. The endosulfan sulfate concentrations were only related to the levels of endosulfan diol. Finally, a clear correlation was found between the cyclodiene compounds. These correlations were significant for the pairs dieldrin-aldrin (|Ω0.182; pϽ0.0001) and endrin-aldrin (|Ω0.185, pϽ0.001). This suggests a relationship between parent compounds and derivatives.
Interestingly, given the purpose of our study, no correlation was found between the content of a single pesticide in the a-fraction and the estrogenicity determined in the bioassay. No single organochlorine could predict the estrogenicity of a sample. There may be several reasons for this lack of concordance: i) the estrogenic effects depicted in the E-Screen bioassay are a consequence of the combined effect of several organochlorines; ii) the proliferative effect is due to other chemicals not measured, either other organochlorine pesticides or other lipophilic compounds. The present work sheds some new light on this issue. Whereas the estrogenicity of endosulfan I and II was already known (21), we also identified endosulfan diol and ether as estrogenic in the E-Screen bioassay (range 10-100 mM). All of these four chemicals were positively identified among the organochlorine pesticides that bioaccumulated in the fat samples of the present series. They eluted in the a-fraction of the preparative HPLC and may therefore account for the positivity of the samples in the E-Screen.
Bisphenol-A, fluorine-containing bisphenol-A (bisphenol-AF) and other bisphenol derivatives are estrogenic for MCF-7 cells, promoting cell proliferation and increasing the synthesis and secretion of cell-type specific proteins (32) . We have also demonstrated, to our knowledge for the first time, the estrogenic activity of four chlorinated bisphenols. All of them induced the proliferation of MCF-7 cells in culture at concentrations of 1 mM and higher. These chlorinated compounds eluted in the a-fraction together with the organochlorine pesticides. Interestingly, other halogenated bisphenols such as prefluorinated bisphenol (MM7) and non-halogenated bisphenol A-related compounds eluted at longer times and were collected in the HPLC ß-fraction.
Since 1991, p-nonylphenol has been identified as an estrogen agonist released from modified polystyrene (32) but no information has been presented on the estrogenicity of their halogenated derivatives. Three brominated derivatives of p-nonylphenol were included in the present study and all were estrogenic in the EScreen bioassay. These brominated alkylphenols were also collected in the HPLC a-fraction, reflecting their fat solubility. The presence in adipose tissue of these brominated alkylphenols and the chlorinated bisphenols has yet to be demonstrated. However, if they do bioaccumulate in adipose tissue, this may also account for the estrogenicity of the a-fractions.
Finally, the ß-fraction, where additives and monomers of plastics eluted, such as bisphenol A, phytoestrogens, mycoestrogens and sex-hormones, was estrogenic in 83% of the samples assayed. The mean value of Eeq/g of lipid for the ß-fraction was established at 903 pM/g of lipid for 333 patients. After taking into account the quantification limit, 76% of the samples were finally considered to be positive. When analysing the estrogenicity of ß-fractions, it must be borne in mind that natural estrogens are produced in adipose tissue and subsequently accumulate (33) (34) . The role of natural estrogens and xenoestrogens in the estrogenicity of the ß-fraction is an intriguing issue that warrants further investigation. Our laboratory is currently examining the estrogenic contribution of the phyto-and myco-estrogens, synthetic 195 hormones and bisphenols that eluted in the present HPLC ß-fraction.
Concerns about the role of environmental and dietary estrogens as contributors to the increasing incidence of hormone-related diseases have prompted epidemiologists and clinicians to design patient-based studies in which to test their hypotheses. However, the study of etiologic factors in diseases is not a simple task when the period of exposure is far removed from the clinical presentation of the disease. This can be observed in studies that have attempted to link breast cancer risk to organochlorines content in adipose tissue. A positive association was found for some PCBs (11-14) but was not clearly established for a mixture of PCBs, DDE, HCB, b-HCH, mirex and chlordane (14) . It is possible that a relationship between long-latency diseases and organochlorine exposure cannot be demonstrated from the levels of a single xenoestrogen or of only a few of them. Most studies have estimated the circulating levels or adipose content of one or a small number of chemicals, and have ignored the impact of other chemicals and also the cumulative effects of chemical mixtures in the environment, which cannot be assessed by the testing of isolated chemicals. The method we proposed may help to establish a relationship between the content of xenoestrogens in adipose tissue and the risk of hormonal diseases.
